欢迎访问西安瑞禧生物技术有限公司官方网站

图片名

全国订购热线:
18966759382

首页 > 新闻资讯 > 行业新闻

行业新闻
行业新闻 市场活动 技术资讯

Brexpiprazole S-oxide-d8,DM-3411 d8「同位素标记抑制剂」

作者:瑞禧生物 发布时间:2025-06-09 16:26:14 次浏览

生物活性:Brexpiprazole S-oxide-d8 is a deuterium labeled Brexpiprazole S-oxide. Brexpiprazole S-oxide is a main metabolite of Brexpiprazole and is metabolized by cytochrome P450 3A4 (CYP3A4). Brexpiprazole is an atypical antipsychotic agent and a partial agonist of human 5-HT1A and dopamine receptor with Kis of 0.12 nM and 0.3 nM, respectively. Brexpiprazole is also a 5-HT2A receptor antagonist with a Ki of 0.47 nM[1][2][3].
IC50 & Target[2]
5-HT1A Receptor
0.12 nM (Ki)
5-HT2A Receptor
0.47 nM (Ki)
D2 Receptor
0.3 nM (Ki)
分子量:457.61
Formula:C25H19D8N3O3S
CAS 号:2748605-29-8
非标记 CAS:1191900-51-2
性状:固体
颜色:White to off-white
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Powder:-20°C:3 years,4°C:2 years
In solvent:-80°C:6 months,-20°C:1 month